Research Analysts Set Expectations for CELZ Q2 Earnings
Creative Medical Technology Holdings, Inc. (NASDAQ:CELZ – Free Report) – Equities researchers at Roth Capital decreased their Q2 2025 earnings estimates for shares of Creative Medical Technology in a research report issued to clients and investors on Wednesday, June 4th. Roth Capital analyst J. Aschoff now anticipates that the company will earn ($0.63) per share […]
